ClariVest Asset Management LLC increased its position in shares of UnitedHealth Group Inc. (NYSE:UNH) by 0.1% during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 350,075 shares of the healthcare conglomerate’s stock after buying an additional 381 shares during the period. UnitedHealth Group accounts for 1.5% of ClariVest Asset Management LLC’s holdings, making the stock its 13th largest position. ClariVest Asset Management LLC’s holdings in UnitedHealth Group were worth $49,430,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently modified their holdings of UNH. Benjamin F. Edwards & Company Inc. boosted its position in shares of UnitedHealth Group by 91.8% in the second quarter. Benjamin F. Edwards & Company Inc. now owns 1,082 shares of the healthcare conglomerate’s stock worth $153,000 after buying an additional 518 shares during the period. Evanson Asset Management LLC acquired a new position in shares of UnitedHealth Group during the second quarter worth $201,000. Parametrica Management Ltd acquired a new position in shares of UnitedHealth Group during the second quarter worth $201,000. Franklin Street Advisors Inc. NC acquired a new position in shares of UnitedHealth Group during the second quarter worth $208,000. Finally, Financial Architects Inc boosted its position in shares of UnitedHealth Group by 23.0% in the second quarter. Financial Architects Inc now owns 1,558 shares of the healthcare conglomerate’s stock worth $220,000 after buying an additional 291 shares during the period. 85.78% of the stock is owned by institutional investors.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

UnitedHealth Group Inc. (NYSE:UNH) traded up 0.14% during midday trading on Friday, hitting $136.66. 2,568,703 shares of the stock traded hands. The company has a 50-day moving average of $137.80 and a 200-day moving average of $136.35. UnitedHealth Group Inc. has a 1-year low of $107.51 and a 1-year high of $144.48. The stock has a market cap of $130.15 billion, a PE ratio of 21.39 and a beta of 0.57.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, July 19th. The healthcare conglomerate reported $1.96 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.89 by $0.07. UnitedHealth Group had a net margin of 3.51% and a return on equity of 19.08%. The company had revenue of $46.50 billion for the quarter, compared to analyst estimates of $45.05 billion. On average, equities analysts expect that UnitedHealth Group Inc. will post $7.90 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 20th. Stockholders of record on Friday, September 9th were paid a dividend of $0.625 per share. The ex-dividend date was Tuesday, September 6th. This represents a $2.50 annualized dividend and a dividend yield of 1.83%. UnitedHealth Group’s dividend payout ratio (DPR) is 39.12%.

A number of research analysts have recently weighed in on UNH shares. Leerink Swann reissued an “outperform” rating on shares of UnitedHealth Group in a research note on Sunday, August 21st. Sanford C. Bernstein reissued an “outperform” rating and set a $178.00 price objective on shares of UnitedHealth Group in a research note on Tuesday, September 6th. Royal Bank Of Canada raised their price objective on shares of UnitedHealth Group from $157.00 to $165.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 20th. Credit Suisse Group AG reissued a “buy” rating and set a $148.00 price objective on shares of UnitedHealth Group in a research note on Wednesday, June 29th. Finally, Zacks Investment Research cut shares of UnitedHealth Group from a “hold” rating to a “sell” rating in a research note on Monday, July 18th. One research analyst has rated the stock with a hold rating, twenty-five have given a buy rating and one has issued a strong buy rating to the company. UnitedHealth Group has an average rating of “Buy” and a consensus price target of $155.35.

In other news, Director Richard T. Burke sold 40,000 shares of the stock in a transaction on Wednesday, September 7th. The shares were sold at an average price of $135.31, for a total transaction of $5,412,400.00. Following the transaction, the director now owns 2,003,550 shares in the company, valued at approximately $271,100,350.50. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 1.65% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

5 Day Chart for NYSE:UNH

Receive News & Stock Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related stocks with our FREE daily email newsletter.